5.5mil left isn't too bad. Certainly the rate of spend will increase significantly with HA trials starting.
Maybe the banks are waiting for official product launch / initial sales before signing off on loan?
Certainly no surprises in this quarterly.
Good to see the fin review finally acknowledge ACL with the snippet it had on the weekend.
Anyone else got thoughts re quarterly?
Ann: Appendix 4C - quarterly , page-2
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable